- Accueil >
- Publications >
- Adjuvant Trastuzumab Emtansine (T-DM1) and Concurrent Radiotherapy for Residual Invasive HER2-positive Breast Cancer
Adjuvant Trastuzumab Emtansine (T-DM1) and Concurrent Radiotherapy for Residual Invasive HER2-positive Breast Cancer
Auteurs
Zita Zolcsák, Delphine Loirat, Alain Fourquet, Youlia M. Kirova